Intelicanna Ltd Cash Flow Conversion Efficiency
Intelicanna Ltd cash flow conversion efficiency. Based on the latest financial reports, Intelicanna Ltd (INTL) has a cash flow conversion efficiency ratio of -0.025x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-194.89 Million ≈ $-522.48K USD) by net assets (ILA7.77 Billion ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Intelicanna Ltd (2012–2022)
Cash flow conversion efficiency of Intelicanna Ltd from 2012 to 2022. This chart illustrates how Intelicanna Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Intelicanna Ltd for real-time trading data and today's change.
Intelicanna Ltd Cash Flow Conversion Ratio Explained
Intelicanna Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Intelicanna Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Intelicanna Ltd ranked by their cash flow conversion efficiency. Also see Intelicanna Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Biofil Chemicals & Pharmaceuticals Limited
NSE:BIOFILCHEM
|
-0.167x |
|
Nandani Creation Limited
NSE:JAIPURKURT
|
-0.166x |
|
Gaxos.ai Inc
NASDAQ:GXAI
|
-0.067x |
|
BetterLife Pharma Inc
F:NPAU
|
0.030x |
|
Adalta Ltd
AU:1AD
|
2.240x |
|
TruCap Finance Limited
NSE:TRU
|
1.175x |
|
Bulletin Resources Ltd
AU:BNR
|
-0.046x |
|
Balkrishna Paper Mills Limited
NSE:BALKRISHNA
|
0.020x |
Annual Cash Flow Conversion Efficiency for Intelicanna Ltd (2012–2022)
The table below shows the annual cash flow conversion efficiency of Intelicanna Ltd from 2012 to 2022. Review INTL free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | ILA7.77 Billion ≈ $20.84 Million |
ILA-286.06 Million ≈ $-766.91K |
-0.037x | -166.91% |
| 2021-12-31 | ILA6.78 Billion ≈ $18.17 Million |
ILA372.78 Million ≈ $999.41K |
0.055x | +110.63% |
| 2020-12-31 | ILA7.04 Billion ≈ $18.88 Million |
ILA-3.64 Billion ≈ $-9.77 Million |
-0.518x | -2543.55% |
| 2019-12-31 | ILA8.07 Billion ≈ $21.64 Million |
ILA-158.05 Million ≈ $-423.74K |
-0.020x | +91.86% |
| 2018-12-31 | ILA7.19 Billion ≈ $19.28 Million |
ILA-1.73 Billion ≈ $-4.64 Million |
-0.240x | -63.55% |
| 2017-12-31 | ILA6.87 Billion ≈ $18.42 Million |
ILA-1.01 Billion ≈ $-2.71 Million |
-0.147x | -581.67% |
| 2016-12-31 | ILA5.99 Billion ≈ $16.07 Million |
ILA182.92 Million ≈ $490.39K |
0.031x | +106.88% |
| 2015-12-31 | ILA4.91 Billion ≈ $13.17 Million |
ILA-2.18 Billion ≈ $-5.84 Million |
-0.444x | +24.51% |
| 2014-12-31 | ILA4.89 Billion ≈ $13.12 Million |
ILA-2.88 Billion ≈ $-7.71 Million |
-0.588x | -1336.24% |
| 2013-12-31 | ILA4.41 Billion ≈ $11.84 Million |
ILA-180.63 Million ≈ $-484.25K |
-0.041x | +58.50% |
| 2012-12-31 | ILA33.29 Billion ≈ $89.24 Million |
ILA-3.28 Billion ≈ $-8.80 Million |
-0.099x | -- |
About Intelicanna Ltd
Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.